Sigma Planning Corp’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,000
| Closed | -$230K | – | 1219 |
|
|
2024
Q3 | $230K | Buy |
+2,000
| New | +$230K | 0.01% | 1073 |
|
|
2024
Q2 | – | Sell |
-10,100
| Closed | -$1.39M | – | 1224 |
|
|
2024
Q1 | $1.39M | Buy |
+10,100
| New | +$1.39M | 0.04% | 403 |
|
|
2020
Q3 | – | Sell |
-3,795
| Closed | -$463K | – | 1115 |
|
|
2020
Q2 | $463K | Buy |
+3,795
| New | +$463K | 0.02% | 618 |
|
|
2018
Q4 | – | Sell |
-2,370
| Closed | -$291K | – | 909 |
|
|
2018
Q3 | $291K | Hold |
2,370
| – | – | 0.02% | 697 |
|
|
2018
Q2 | $233K | Sell |
2,370
-1,020
| -30% | -$100K | 0.02% | 760 |
|
|
2018
Q1 | $281K | Buy |
3,390
+290
| +9% | +$24K | 0.02% | 630 |
|
|
2017
Q4 | $241K | Buy |
+3,100
| New | +$241K | 0.02% | 691 |
|